The role of ADCP or trogocytosis in the human clinical setting is unclear, but has some impact, given the known infiltration of HER2+ breast cancer by macrophages, which is augmented upon trastuzumab administration [90,101]. The gene discussed is ERBB2; the disease is breast carcinoma.